Novavax to Present at the 27th Annual Piper Jaffray Healthcare Conference
November 24 2015 - 4:05PM
Novavax, Inc. (Nasdaq:NVAX), a clinical-stage vaccine company
focused on the discovery, development and commercialization of
recombinant nanoparticle vaccines and adjuvants, today announced
that Stanley C. Erck, President and CEO, will present at the 27th
Annual Piper Jaffray Healthcare Conference.
Conference details are as follows:
Date: Tuesday, December 1, 2015Time: 2:00 p.m.
U.S. Eastern TimeLocation: New York Palace Hotel, New York CityLive
webcast: http://edge.media-server.com/m/p/ui3ne8dn
The webcast and a replay of the presentation
will also be accessible under the “Investors/Events” section of the
Novavax website at novavax.com.
About Novavax
Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage
vaccine company committed to delivering novel products to prevent a
broad range of infectious diseases. Our recombinant nanoparticles
and Matrix-M™ adjuvant technology are the foundation for
groundbreaking innovation that improves global health through safe
and effective vaccines. Additional information about Novavax is
available on the Company’s website, novavax.com.
Contact:
Novavax, Inc.
Barclay A. Phillips
SVP, Chief Financial Officer and Treasurer
Andrea N. Flynn, Ph.D.
Senior Manager, Investor Relations
ir@novavax.com
240-268-2000
Russo Partners, LLC
David Schull
Todd Davenport, Ph.D.
david.schull@russopartnersllc.com
todd.davenport@russopartnersllc.com
212-845-4271
Novavax (NASDAQ:NVAX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Novavax (NASDAQ:NVAX)
Historical Stock Chart
From Sep 2023 to Sep 2024